LIN
8/17/26

LINDE (LIN)

Monday
4:37 AM
Thesis: Linde's strategic investments in hydrogen and healthcare are expected to drive significant revenue growth, enhancing its competitive position in the industrial gases market.

Revenue Outlook

MetricFY2025FY2026EFY2027E
Revenue$34.0B$36.2B$37.9B
Rev. Growth+3.0%+6.4%+4.9%
EPS$14.67$17.90$19.62
EPS Growth+7.0%+22.0%+9.6%
P/E (fwd)32.9×27.0×24.6×
Analysts see FY2026 revenue reaching $36.2B +6.4% growth in a single year.

What’s Driving the Stock

  1. 1Linde's recent investment in a new hydrogen production facility in Texas is expected to increase hydrogen supply by 25%, positioning it favorably in the growing clean energy market.
  2. 2The company's ongoing cost-reduction initiatives are projected to enhance operating margins by 150 basis points over the next year.
  3. 3Linde's expansion into the Asia-Pacific region is expected to drive revenue growth by 10% annually as demand for industrial gases rises in emerging markets.
  4. 4Increased healthcare spending in the U.S. is anticipated to boost demand for medical gases, potentially increasing revenue by 5% in the next fiscal year.
  5. 5Transition to clean energy and hydrogen economy
  6. 6Increased focus on healthcare and medical gas applications
  7. 7Global industrial production levels, particularly in manufacturing sectors
  8. 8Natural gas prices, impacting production costs
FY2025 Snapshot
Revenue
$34.0B
EPS
$14.67

LIN Chart

436465495524554482.74LIN Daily482.74Mar '26May '26Jun '26Aug '26

My Notes

  • "Linde is poised to capitalize on the growing demand for clean energy solutions and healthcare applications."
  • Moat: Linde's competitive advantage is bolstered by its extensive distribution network and technological expertise…
  • value - Linde's strong cash flow generation and solid margins appeal to value investors looking for stable returns.
  • Rising interest rates can increase Linde's financing costs for capital expenditures…
  • Watch on earnings: Industrial Production Index (INDPRO), Natural gas prices (NGUSD), Healthcare demand metrics.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $36.2B to $37.9B as linde's recent investment in a new hydrogen production facility in texas is expected to increase hydrogen supply by 25%.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.